JPS5341202B2 - - Google Patents
Info
- Publication number
- JPS5341202B2 JPS5341202B2 JP2931874A JP2931874A JPS5341202B2 JP S5341202 B2 JPS5341202 B2 JP S5341202B2 JP 2931874 A JP2931874 A JP 2931874A JP 2931874 A JP2931874 A JP 2931874A JP S5341202 B2 JPS5341202 B2 JP S5341202B2
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2931874A JPS5341202B2 (ja) | 1974-03-12 | 1974-03-12 | |
FR7507594A FR2263786B1 (ja) | 1974-03-12 | 1975-03-11 | |
GB1007475A GB1457382A (en) | 1974-03-12 | 1975-03-11 | Process for preparing live varticella vaccines |
BE2054201A BE826568A (fr) | 1974-03-12 | 1975-03-12 | Procede de preparation de vaccins vivants contre la varicelle |
US05/557,724 US3985615A (en) | 1974-03-12 | 1975-03-12 | Process for preparing live varicella vaccines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2931874A JPS5341202B2 (ja) | 1974-03-12 | 1974-03-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS50123817A JPS50123817A (ja) | 1975-09-29 |
JPS5341202B2 true JPS5341202B2 (ja) | 1978-11-01 |
Family
ID=12272859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2931874A Expired JPS5341202B2 (ja) | 1974-03-12 | 1974-03-12 |
Country Status (5)
Country | Link |
---|---|
US (1) | US3985615A (ja) |
JP (1) | JPS5341202B2 (ja) |
BE (1) | BE826568A (ja) |
FR (1) | FR2263786B1 (ja) |
GB (1) | GB1457382A (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997043420A1 (fr) * | 1996-05-15 | 1997-11-20 | The Research Foundation For Microbial Diseases Of Osaka University | Procede d'identification de la souche oka ou souche derivee de celle-ci du virus attenue de la varicelle et acceptable comme virus attenue du vaccin contre la varicelle |
WO2008059959A1 (fr) | 2006-11-17 | 2008-05-22 | The Research Foundation For Microbial Diseases Of Osaka University | Agent promoteur de l'étirement des nerfs et agent inhibiteur de l'étirement des nerfs |
JP4676063B2 (ja) * | 1999-02-25 | 2011-04-27 | 一般財団法人阪大微生物病研究会 | 弱毒水痘ウイルス岡株の遺伝子62とこの遺伝子62を用いる弱毒生水痘ワクチン用ウイルス株の同定方法 |
JP2013500024A (ja) * | 2009-07-28 | 2013-01-07 | ニュージャージー メディカル スクール | Orf7欠損水痘ウイルス、該ウイルスを含むワクチン、及びその使用 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2077590A (en) * | 1980-01-25 | 1981-12-23 | Wistar Inst | Highly attenuated varicella virus vaccine and production thereof |
US4315914A (en) * | 1980-04-04 | 1982-02-16 | Seiji Arakawa | Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof |
NZ220645A (en) * | 1986-06-20 | 1989-10-27 | Merck & Co Inc | Modified varicella-zoster virus and its cultivation |
IL86180A (en) * | 1987-05-04 | 1992-08-18 | Merck & Co Inc | Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines |
US5360736A (en) * | 1992-06-04 | 1994-11-01 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
UA27137C2 (uk) * | 1992-06-04 | 2000-02-28 | Мерк Енд Ко., Інк. | Спосіб одержаhhя вакциhи hа осhові живого атеhуйов |
CA2139515C (en) | 1992-07-17 | 2008-12-23 | Gary B. Calandra | Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
KR0177323B1 (ko) * | 1996-02-16 | 1999-04-01 | 성재갑 | 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법 |
US6051238A (en) * | 1996-12-20 | 2000-04-18 | Merck & Co., Inc. | Stabilizers for lyophilized mumps vaccines |
GB9804632D0 (en) | 1998-03-05 | 1998-04-29 | Cantab Pharma Res | Virus preparations and methods |
GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
US6528066B1 (en) | 1999-09-14 | 2003-03-04 | University Of Iowa Research Foundation | Variant varicella-zoster viruses and methods of use |
AU2003295398A1 (en) * | 2002-11-05 | 2004-06-07 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Safer attenuated virus vaccines with missing or diminished latency of infection |
US8916175B2 (en) * | 2004-06-29 | 2014-12-23 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection |
US7344839B2 (en) * | 2004-12-23 | 2008-03-18 | Aurx, Inc. | Virus preparations and methods |
GB0504436D0 (en) | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
US10166285B2 (en) | 2006-11-09 | 2019-01-01 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Recombinant virus with diminished latency and methods of using same |
UA112970C2 (uk) | 2010-08-05 | 2016-11-25 | Мерк Шарп Енд Доме Корп. | Інактивований вірус вітряної віспи, спосіб його одержання і застосування |
EP2686423A4 (en) | 2011-03-14 | 2015-01-28 | Nat Res Council Canada | METHOD FOR PRODUCING VIRUSES IN CELLS |
US10232035B2 (en) | 2012-09-14 | 2019-03-19 | The Regents Of The University Of Colorado, A Body Corporate | Conditionally replication deficient herpes virus and use thereof in vaccines |
SG11201803594TA (en) | 2015-11-06 | 2018-05-30 | Adjuvance Technologies Inc | Triterpene saponin analogues |
-
1974
- 1974-03-12 JP JP2931874A patent/JPS5341202B2/ja not_active Expired
-
1975
- 1975-03-11 FR FR7507594A patent/FR2263786B1/fr not_active Expired
- 1975-03-11 GB GB1007475A patent/GB1457382A/en not_active Expired
- 1975-03-12 US US05/557,724 patent/US3985615A/en not_active Expired - Lifetime
- 1975-03-12 BE BE2054201A patent/BE826568A/xx not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997043420A1 (fr) * | 1996-05-15 | 1997-11-20 | The Research Foundation For Microbial Diseases Of Osaka University | Procede d'identification de la souche oka ou souche derivee de celle-ci du virus attenue de la varicelle et acceptable comme virus attenue du vaccin contre la varicelle |
JP4676063B2 (ja) * | 1999-02-25 | 2011-04-27 | 一般財団法人阪大微生物病研究会 | 弱毒水痘ウイルス岡株の遺伝子62とこの遺伝子62を用いる弱毒生水痘ワクチン用ウイルス株の同定方法 |
WO2008059959A1 (fr) | 2006-11-17 | 2008-05-22 | The Research Foundation For Microbial Diseases Of Osaka University | Agent promoteur de l'étirement des nerfs et agent inhibiteur de l'étirement des nerfs |
JP2013500024A (ja) * | 2009-07-28 | 2013-01-07 | ニュージャージー メディカル スクール | Orf7欠損水痘ウイルス、該ウイルスを含むワクチン、及びその使用 |
Also Published As
Publication number | Publication date |
---|---|
JPS50123817A (ja) | 1975-09-29 |
US3985615A (en) | 1976-10-12 |
FR2263786A1 (ja) | 1975-10-10 |
GB1457382A (en) | 1976-12-01 |
BE826568A (fr) | 1975-09-12 |
FR2263786B1 (ja) | 1978-12-01 |